Likelihood inference for a two-stage design with treatment selection

Biometrical Journal

Volumn 52, Issue 6, 2010, Pages 811-822

  Bebu, Ionut ^a   Luta, George ^a   Dragalin, Vladimir ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Confidence intervals; Likelihood; Seamless Phase II III designs

Indexed keywords

FINANCIAL DATA PROCESSING;

CONDITIONAL LIKELIHOOD; CONFIDENCE INTERVAL; COVERAGE PROBABILITIES; LIKELIHOOD; LIKELIHOOD RATIO TESTS; OPERATING CHARACTERISTICS; PHASE II; SEAMLESS PHASE II/III DESIGN; TREATMENT SELECTION; TWO STAGE DESIGNS;

MEAN SQUARE ERROR;

EID: 78650142377     PISSN: 03233847     EISSN: 15214036     Source Type: Journal    
DOI: 10.1002/bimj.200900170     Document Type: Article

References (23)

1. Bauer, P. and Kieser, M. (1999). Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 18, 1833-1848.
2. Bauer, P. and Köhne, K. (1994). Evaluation of experiments with adaptive interim analyses. Biometrics 50, 1029-1041.
3. Bauer, P., Koenig, F., Brannath, W. and Posch, M. (2010). Selection and bias-Two hostile brothers. Statistics in Medicine 29, 1-13.
4. Bowden, J. and Glimm, E. (2008). Unbiased estimation of selected means in two-stage trials. Biometrical Journal 50, 515-527.
5. Brannath, W., Koenig, F. and Bauer, P. (2006). Estimation in flexible two stage designs. Statistics in Medicine 25, 3366-3381.
6. Brannath, W., Koenig, F. and Bauer, P. (2007). Multiplicity and flexibility in clinical trials. Pharmaceutical Statistics 6, 205-216.
7. Brannath, W., Posch, M. and Bauer, P. (2002). Recursive combination tests. Journal of the American Statistical Association 97, 236-244.
8. Brannath, W., Zuber, E., Branson, M., Bretz, F., Gallo, P., Posch, M. and Racine-Poon, A. (2009). Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology. Statistics in Medicine 28, 1445-1463.
9. Bretz, F., Koenig, F., Branath, W., Glimm, E. and Posch, M. (2009). Adaptive designs for confirmatory clinical trials. Statistics in Medicine 28, 1181-1217.
10. Cohen, A. and Sackrowitz, H. (1989). Two stage conditionally unbiased estimators of the selected mean. Statistics and Probability Letters 8, 273-278.
11. Kelly, P. J., Stallard N. and Todd, S. (2005). An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several. Journal of Biopharmaceutical Statistics 15, 641--658.
12. Kenward, M.G. and Molenberghs, G. (1998). Likelihood based frequentist inference when data are missing at random. Statistical Science 13, 236-247.
13. Liu, Q. and Pledger, G. W. (2005). Phase II and III combination designs to accelerate drug development. Journal of the American Statistical Association 100, 493-502.
14. Maca, J., Bhattacharya, S., Dragalin, V., Gallo, P., Krams, M. (2006). Adaptive seamless phase II/III designs - background, operational aspects, and examples. Drug Information Journal 4, 463-473.
15. Müller, H. H. and Schäfer, H. (2001). Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and classical group sequential approaches. Biometrics 57, 886-819.
16. Posch, M., Koenig, F., Brannath, W., Dunger-Baldauf, C. and Bauer, P. (2005). Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine 24, 3697-3714.
17. Sampson, A. R. and Sill, M. W. (2005). Drop-the-losers design: normal case. Biometrical Journal 47, 257-268.
18. Schmidli, H., Bretz, F., Racine, A. and Maurer, W. (2006). Confirmatory seamless phase II/III clinical trials with hypothesis selection at interim: Applications and practical considerations. Biometrical Journal 48, 635-643.
19. Song, P.X.-K., Fan, Y. and Kalbfleisch, J. D. (2005). Maximization by parts in likelihood inference. Journal of the American Statistical Association 100, 1145-1158.
20. Stallard, N. and Friede, T. (2008). A group-sequential design for clinical trials with treatment selection. Statistics in Medicine 27, 6209-6227.
21. Stallard, N. and Todd, S. (2005). Point estimates and confidence regions for sequential trials involving selection. Journal of Statistical Planning and Inference 135, 402-419.
22. Stallard, N., Todd, S. and Whitehead, J. (2008). Estimation following selection of the largest of two normal means. Journal of Statistical Planning and Inference 138, 1629-1638.
23. U. S. Food and Drug Administration (2004). Challenges and Opportunity on the Critical Path to New Medical Products. Available at .